LLY vs SYK
By Alex · Tickerpine
Eli Lilly and Company vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | SYK |
|---|---|---|
| Price | $1,443.50 | $309.64 |
| Market cap | $1.29T | $117.88B |
| P/E ratio | 46.9 | 33.0 |
| ROE | 86.02% | 16.02% |
| Profit margin | 31.90% | 13.78% |
| Revenue growth | 38.60% | 7.60% |
| Dividend yield | 0.48% | 1.14% |
| Beta | 0.39 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs SYK in plain English
- LLY is the bigger company — about 10.9× the market cap of SYK.
- SYK is cheaper on earnings (P/E 33.0 vs 46.9).
- LLY earns a higher return on equity (86% vs 16%).
- LLY is growing revenue faster (39% vs 8%).
- SYK has the higher dividend yield (1.14% vs 0.48%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.